Eli Lilly and Co

Trash and dollar stores: Analysts are starting to give their top stocks to own in a recession
World

Trash and dollar stores: Analysts are starting to give their top stocks to own in a recession

With the market selling off on fears of an imminent recession, individual stock analysts are starting to trot out their top stock picks to own in an economic downturn. A number of reports to clients of Wall Street banks this week focused on stocks that have resilient revenues and business models. Stocks fell deeper into […]

Read More
Cramer’s lightning round: Applied Materials is a buy
Business

Cramer’s lightning round: Applied Materials is a buy

“Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at rapid speed. Source

Read More
Here are 5 Investing Club stocks in the news and our take on what’s happening
Health

Here are 5 Investing Club stocks in the news and our take on what’s happening

We break down five developments involving our stocks including Apple, Qualcomm and Eli Lilly. Source

Read More
Eli Lilly’s new diabetes drug continues to show promise as an obesity treatment
Business

Eli Lilly’s new diabetes drug continues to show promise as an obesity treatment

Eli Lilly continues to work on commercializing its strong innovation pipeline, which is a key reason the CNBC Investing Club owns the stock. Source

Read More
We’re changing our price targets on 8 stocks in the portfolio
Health

We’re changing our price targets on 8 stocks in the portfolio

The moves reflect recent earnings reports, comments from company executives, and general market multiple compression. Source

Read More
Stocks making the biggest moves midday: Sunrun, Eli Lilly, DiDi Global, CrowdStrike and more
Finance

Stocks making the biggest moves midday: Sunrun, Eli Lilly, DiDi Global, CrowdStrike and more

Tim McKibben, left, a senior installer for the solar company, Sunrun, and installer Aaron Newsom install solar panels on the roof of a home in Granada Hills. Mel Melcon | Los Angeles Times | Getty Images Check out the companies making headlines in midday trading Monday. Solar companies — Solar stocks jumped after the Biden […]

Read More
Stocks making the biggest moves in the premarket: Spirit Airlines, Didi Global, Keurig Dr Pepper and more
Finance

Stocks making the biggest moves in the premarket: Spirit Airlines, Didi Global, Keurig Dr Pepper and more

Take a look at some of the biggest movers in the premarket: Spirit Airlines (SAVE) – Spirit jumped 6.1% in the premarket after JetBlue (JBLU) sweetened its bid for Spirit. JetBlue will increase its breakup fee for the deal to $350 million and pay part of that as a dividend if the deal is consummated, […]

Read More
When the market was tanking, these stocks were hitting all-time highs and could go even higher
Health

When the market was tanking, these stocks were hitting all-time highs and could go even higher

While market losses were racking up, this group of stocks was breaking out to all-time highs and looks set for even more gains. The group is Big Pharma. It’s been long viewed as stodgy by investors looking for quicker price gains. Recently, however, as other stocks slid, these companies have become more attractive because of […]

Read More
Stocks making the biggest moves midday: JPMorgan Chase, Gap, VMWare & more
Business

Stocks making the biggest moves midday: JPMorgan Chase, Gap, VMWare & more

People pass the JP Morgan Chase & Co. Corporate headquarters in the Manhattan borough of New York City. Mike Segar | Reuters Check out the companies making headlines in midday trading. JPMorgan Chase – JPMorgan rose 7% after the bank said it expects to reach key return targets sooner than planned thanks to rising interest rates giving […]

Read More
Eli Lilly’s new diabetes drug continues to show promise as an obesity treatment
Business

Eli Lilly’s ‘game-changing’ diabetes drug could boost the stock, SVB Securities says

Eli Lilly ‘s new diabetes drug, which may also address obesity in patients, could lead to even more gains for the company’s stock, according to SVB Securities. Analyst David Risinger initiated coverage of Eli Lilly with an outperform rating, saying in a Sunday note that investors are failing to price in the potential of tirzepatide, […]

Read More